Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Mar;63(3):840–846. doi: 10.1128/iai.63.3.840-846.1995

Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species.

D M Delahooke 1, G R Barclay 1, I R Poxton 1
PMCID: PMC173079  PMID: 7532627

Abstract

The stimulation of macrophages and monocytes by lipopolysaccharide (LPS) results in the secretion of tumor necrosis factor (TNF), a cytokine which is thought to play a pivotal role in subsequent host responses. Its induction is thought to be facilitated by the binding of complexes of LPS and LPS-binding protein to CD14. The LPS of Bacteroides species was considered a weak endotoxin; however, in a recent study we have shown that the biological activity and chemical composition of the LPS from Bacteroides species are dependent on the extraction method. The present study determines the capacity of LPS extracted by aqueous phenol (the method for producing an LPS of high endotoxic activity) from four species of Bacteroides to induce TNF. Induction was investigated from human mononuclear leukocytes (MNL), THP-1 cells (with and without enhancement by vitamin D2 for CD14), and peritoneal macrophages from C3H/HeJ (LPS nonresponder) and C3H/HeN (LPS responder) mice. Escherichia coli O18K- LPS, a typical smooth LPS of heterogeneous molecular mass, was used as a control throughout. The stimulation of TNF production by E. coli LPS was between two- and fourfold more than that by Bacteroides LPS in MNL, in THP-1 cells (with enhancement for CD14), and in peritoneal macrophages from C3H/HeN mice. In THP-1 cells (without enhancement for CD14), there was no significant difference in TNF production between E. coli and Bacteroides LPSs. In peritoneal macrophages from C3H/HeJ mice, E. coli LPS stimulated no TNF production, but there was no significant difference in TNF production from peritoneal macrophages from C3H/HeJ and C3H/HeN mice by Bacteroides LPS. In all cell populations, there was a peak of TNF production after approximately 4 h of stimulation with all LPSs tested. However, other peaks of TNF production were seen in MNL and THP-1 cells (with enhancement for CD14) after stimulation with E. coli LPS only. In stimulation assays in which Bacteroides LPS was together with but in excess of E. coli LPS, it was found that TNF production from MNL and THP-1 cells (with and without enhancement for CD14) was comparable to that of Bacteroides LPS alone and not E. coli LPS alone. An anti-CD14 monoclonal antibody did not inhibit Bacteroides LPS-stimulated TNF production. However, E. coli LPS-stimulated TNF release was inhibited by an anti-CD14 monoclonal antibody, most noticeably in MNL and THP-1 cells (with enhancement for CD14).(ABSTRACT TRUNCATED AT 400 WORDS)

Full Text

The Full Text of this article is available as a PDF (261.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bone R. C. Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev. 1993 Jan;6(1):57–68. doi: 10.1128/cmr.6.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Callery M. P., Kamei T., Mangino M. J., Flye M. W. Organ interactions in sepsis. Host defense and the hepatic-pulmonary macrophage axis. Arch Surg. 1991 Jan;126(1):28–32. doi: 10.1001/archsurg.1991.01410250032004. [DOI] [PubMed] [Google Scholar]
  3. Cross A. S. Inducing an abscess. Lancet. 1994 Jan 29;343(8892):248–249. doi: 10.1016/s0140-6736(94)91106-1. [DOI] [PubMed] [Google Scholar]
  4. Fujiwara T., Nishihara T., Koga T., Hamada S. Serological properties and immunobiological activities of lipopolysaccharides from black-pigmented and related oral Bacteroides species. J Gen Microbiol. 1988 Nov;134(11):2867–2876. doi: 10.1099/00221287-134-11-2867. [DOI] [PubMed] [Google Scholar]
  5. Galanos C., Lüderitz O., Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969 Jun;9(2):245–249. doi: 10.1111/j.1432-1033.1969.tb00601.x. [DOI] [PubMed] [Google Scholar]
  6. Haziot A., Chen S., Ferrero E., Low M. G., Silber R., Goyert S. M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol. 1988 Jul 15;141(2):547–552. [PubMed] [Google Scholar]
  7. Haziot A., Tsuberi B. Z., Goyert S. M. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol. 1993 Jun 15;150(12):5556–5565. [PubMed] [Google Scholar]
  8. Holbrook W. P., Duerden B. I., Deacon A. G. The classification of Bacteroides melaninogenicus and related species. J Appl Bacteriol. 1977 Apr;42(2):259–273. doi: 10.1111/j.1365-2672.1977.tb00691.x. [DOI] [PubMed] [Google Scholar]
  9. Lindberg A. A., Weintraub A., Zähringer U., Rietschel E. T. Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis. 1990 Jan-Feb;12 (Suppl 2):S133–S141. doi: 10.1093/clinids/12.supplement_2.s133. [DOI] [PubMed] [Google Scholar]
  10. Lutton D. A., Patrick S., Crockard A. D., Stewart L. D., Larkin M. J., Dermott E., McNeill T. A. Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies. J Med Microbiol. 1991 Oct;35(4):229–237. doi: 10.1099/00222615-35-4-229. [DOI] [PubMed] [Google Scholar]
  11. Lynn W. A., Golenbock D. T. Lipopolysaccharide antagonists. Immunol Today. 1992 Jul;13(7):271–276. doi: 10.1016/0167-5699(92)90009-V. [DOI] [PubMed] [Google Scholar]
  12. Lynn W. A., Liu Y., Golenbock D. T. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect Immun. 1993 Oct;61(10):4452–4461. doi: 10.1128/iai.61.10.4452-4461.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Magnuson D. K., Weintraub A., Pohlman T. H., Maier R. V. Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J Immunol. 1989 Nov 1;143(9):3025–3030. [PubMed] [Google Scholar]
  14. Onderdonk A. B., Bartlett J. G., Louie T., Sullivan-Seigler N., Gorbach S. L. Microbial synergy in experimental intra-abdominal abscess. Infect Immun. 1976 Jan;13(1):22–26. doi: 10.1128/iai.13.1.22-26.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Onderdonk A. B., Kasper D. L., Cisneros R. L., Bartlett J. G. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977 Jul;136(1):82–89. doi: 10.1093/infdis/136.1.82. [DOI] [PubMed] [Google Scholar]
  16. Pantosti A., Tzianabos A. O., Reinap B. G., Onderdonk A. B., Kasper D. L. Bacteroides fragilis strains express multiple capsular polysaccharides. J Clin Microbiol. 1993 Jul;31(7):1850–1855. doi: 10.1128/jcm.31.7.1850-1855.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Patrick S., Reid J. H. Separation of capsulate and non-capsulate Bacteroides fragilis on a discontinuous density gradient. J Med Microbiol. 1983 May;16(2):239–241. doi: 10.1099/00222615-16-2-239. [DOI] [PubMed] [Google Scholar]
  18. Poxton I. R., Brown R. Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen. J Gen Microbiol. 1986 Sep;132(9):2475–2481. doi: 10.1099/00221287-132-9-2475. [DOI] [PubMed] [Google Scholar]
  19. Rotstein O. D., Vittorini T., Kao J., McBurney M. I., Nasmith P. E., Grinstein S. A soluble Bacteroides by-product impairs phagocytic killing of Escherichia coli by neutrophils. Infect Immun. 1989 Mar;57(3):745–753. doi: 10.1128/iai.57.3.745-753.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sultzer B. M. Genetic analysis of lymphocyte activation by lipopolysaccharide Endotoxin. Infect Immun. 1976 Jun;13(6):1579–1584. doi: 10.1128/iai.13.6.1579-1584.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  22. Tzianabos A. O., Onderdonk A. B., Rosner B., Cisneros R. L., Kasper D. L. Structural features of polysaccharides that induce intra-abdominal abscesses. Science. 1993 Oct 15;262(5132):416–419. doi: 10.1126/science.8211161. [DOI] [PubMed] [Google Scholar]
  23. Tzianabos A. O., Pantosti A., Baumann H., Brisson J. R., Jennings H. J., Kasper D. L. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem. 1992 Sep 5;267(25):18230–18235. [PubMed] [Google Scholar]
  24. Weintraub A., Larsson B. E., Lindberg A. A. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides. Infect Immun. 1985 Jul;49(1):197–201. doi: 10.1128/iai.49.1.197-201.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Williamson S. I., Wannemuehler M. J., Jirillo E., Pritchard D. G., Michalek S. M., McGhee J. R. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS. J Immunol. 1984 Nov;133(5):2294–2300. [PubMed] [Google Scholar]
  26. Wright S. D. Multiple receptors for endotoxin. Curr Opin Immunol. 1991 Feb;3(1):83–90. doi: 10.1016/0952-7915(91)90082-c. [DOI] [PubMed] [Google Scholar]
  27. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. doi: 10.1126/science.1698311. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES